𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children’s oncology group

✍ Scribed by Patrick A. Thompson; Manish Gupta; Gary L. Rosner; Alexander Yu; Jeffrey Barrett; Lisa Bomgaars; Mark L. Bernstein; Susan M. Blaney; John Mondick

Publisher
Springer
Year
2008
Tongue
English
Weight
440 KB
Volume
62
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pediatric cancer in the United States. A
Pediatric cancer in the United States. A preliminary report of a collaborative study of the childrens cancer group and the pediatric oncology group
✍ Julie A. Ross; Richard K. Severson; Leslie L. Robison; Brad H. Pollock; Joseph P 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 555 KB

## Background: Cancer is the second leading cause of death in children younger than 15 years. although 5-year survival rates have increased dramatically for many childhood tumors, more than 100,000 person-years of life are lost to childhood cancer each year. the exact proportion of pediatric patien

Phase II investigation of docetaxel in p
Phase II investigation of docetaxel in pediatric patients with recurrent solid tumors : A report from the Children's Oncology Group
✍ Ted Zwerdling; Mark Krailo; Philip Monteleone; Rebecca Byrd; Judith Sato; Rose D 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## BACKGROUND Docetaxel, which is an antitubulin agent, has demonstrable activity against murine and human tumors. The current study was designed to determine response rates to docetaxel in various strata of recurrent solid tumors of childhood and to assess toxicity in a group of patie